{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:29:36Z","timestamp":1785713376694,"version":"3.56.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/md.0000000000011687","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T20:52:58Z","timestamp":1533243178000},"page":"e11687","source":"Crossref","is-referenced-by-count":15,"title":["Clinical features and treatment of hereditary hemorrhagic telangiectasia"],"prefix":"10.1097","volume":"97","author":[{"given":"Sen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-75-20210226","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","article-title":"Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network","volume":"9","author":"Lesca","year":"2007","journal-title":"Genet Med"},{"key":"R2-75-20210226","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-1172-7-33","article-title":"A long diagnostic delay in patients with hereditary haemorrhagic telangiectasia: a questionnaire-based retrospective study","volume":"7","author":"Pierucci","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R3-75-20210226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"R4-75-20210226","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/humu.10026","article-title":"Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan","volume":"19","author":"Dakeishi","year":"2002","journal-title":"Hum Mutat"},{"key":"R5-75-20210226","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/pmj.79.927.18","article-title":"Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century","volume":"79","author":"Begbie","year":"2003","journal-title":"Postgrad Med J"},{"key":"R6-75-20210226","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajmg.1320320302","article-title":"Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population","volume":"32","author":"Plauchu","year":"1989","journal-title":"Am J Med Genet"},{"key":"R7-75-20210226","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/imj.12457","article-title":"Hereditary haemorrhagic telangiectasia, an Australian cohort: clinical and investigative features","volume":"44","author":"Salaria","year":"2014","journal-title":"Intern Med J"},{"key":"R8-75-20210226","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0004.2010.01596.x","article-title":"Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion\/duplication analysis","volume":"79","author":"McDonald","year":"2011","journal-title":"Clin Genet"},{"key":"R9-75-20210226","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10456-015-9482-5","article-title":"Executive summary of the 11th HHT international scientific conference","volume":"18","author":"Arthur","year":"2015","journal-title":"Angiogenesis"},{"key":"R10-75-20210226","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood.V128.22.3776.3776","article-title":"Causes and severity of anemia in hereditary hemorrhagic telangiectasia","volume":"128","author":"Kristy","year":"2016","journal-title":"Blood"},{"key":"R11-75-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000103205","article-title":"Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease)","volume":"74","author":"Cottin","year":"2007","journal-title":"Respiration"},{"key":"R12-75-20210226","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.arbres.2013.08.006","article-title":"Pulmonary arteriovenous malformations and embolic complications in patients with hereditary hemorrhagic telangiectasia","volume":"50","author":"Angriman","year":"2014","journal-title":"Arch Bronconeumol"},{"key":"R13-75-20210226","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2377-11-84","article-title":"Stroke in hereditary hemorrhagic telangiectasia patients. New evidence for repeated screening and early treatment of pulmonary vascular malformations: two case reports","volume":"11","author":"Ribeiro","year":"2011","journal-title":"BMC Neurol"},{"key":"R14-75-20210226","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"R15-75-20210226","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia","volume":"16","author":"Lebrin","year":"2010","journal-title":"Nat Med"},{"key":"R16-75-20210226","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2352-3026(15)00195-7","article-title":"Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study","volume":"2","author":"Invernizzi","year":"2015","journal-title":"Lancet Haematol"},{"key":"R17-75-20210226","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4193\/Rhin14.289","article-title":"Follow-up of thalidomide treatment in patients with hereditary haemorrhagic telangiectasia","volume":"53","author":"Hosman","year":"2015","journal-title":"Rhinology"},{"key":"R18-75-20210226","doi-asserted-by":"crossref","first-page":"330","DOI":"10.12998\/wjcc.v3.i4.330","article-title":"Bleeding and clotting in hereditary hemorrhagic telangiectasia","volume":"3","author":"Dittus","year":"2015","journal-title":"World J Clin Cases"},{"key":"R19-75-20210226","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMc1213554","article-title":"Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia","volume":"368","author":"Devlin","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:18Z","timestamp":1620962358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201808030-00075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":19,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011687","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}